Search results
Results From The WOW.Com Content Network
In November 2017, Mayora's Kopiko snacks were photographed at the International Space Station as part of a Thanksgiving dinner held by astronauts. [4] In 2019, Mayora founder and head Jogi Hendra Atmadja was listed by Forbes as the 10th richest person in Indonesia, with wealth of $3 billion. [5]
Atmadja started his career as a banker at Bank Central Asia. [3] In 1977, he founded the Mayora Group with his brothers and sisters. [4] Mayora Group produces and sells various food and beverage products, such as coffee, cereal, candy, biscuits, wafers, chocolate, and instant noodles. [5]
Kopiko is an Indonesian brand of coffee and confectioneries originally produced in Indonesia by Mayora Indah. [1] It is named after the kōpiko coffee bean , found in Hawaii . [ 2 ]
Planet Fitness’s ousted CEO still doesn’t know why he was fired—and he’s not allowed to ask his former colleagues about it either Eleanor Pringle September 22, 2023 at 7:47 AM
Meat is one of the most broken food systems. Food in general is rife with a lot of issues that need to be disrupted. Early on, it started with wanting grass fed beef because we want to eat healthier.
CEO of the Year in the Food and Beverage: GLOBEE Silve Award –2021. [43] [44] CEO of the Year, Hospitality, Travel, Recreation, Leisure; GLOBEE Gold Award –2021. [45] Transformational Leader of the Year. GLOBEE Silver Award –2021. [46] Top CEO of the Year The Rising Star –2021. [47] Fortune 100 Most Powerful People–2024. [48]
Baldvin Oddson, CEO of a Wyoming-based musical-instrument online storefront, the Musicians Club, fired 90% of his staff—99 out of 110 employees and freelancers—via Slack message for missing ...
Peter R. Dolan (born January 6, 1956) is an American business executive.In 2009, he became chairman and CEO of Gemin X Pharmaceuticals after joining the board in July 2008; he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix.